Startups channel feed

The End­points 11: The biotech star­tups mak­ing the biggest bets with the most ex­cit­ing sci­ence in 2023

1 hour ago
Special

A new George Church start­up rais­es $16M. The first-time founders have a ‘crazy vi­sion’ to bring ML to cell ther­a­py

1 hour ago
Financing

Tol­re­mo rais­es $39M Se­ries A to ad­vance drug de­signed to dis­man­tle ear­ly can­cer de­fens­es

Yesterday
Financing

RNA edit­ing start­up launch­es with $30M based on Stan­ford and Uni­ver­si­ty of Tübin­gen re­search

2 days ago
Financing
Cell/Gene Tx

With co­va­lent meds abuzz, RA Cap­i­tal and No­var­tis lead $56M seed round for new start­up

2 days ago
Financing

Lyn­dra lays off 23% of work­ers, to out­source man­u­fac­tur­ing as it ap­proach­es piv­otal read­out next month

5 days ago
People

Neumo­ra, Rayze­Bio ride on­to Nas­daq in IPO dou­ble­head­er, breath­ing life in­to fall list­ings

6 days ago
Financing

Gene ther­a­py biotech Alveo­Gene launch­es with lentivi­ral plat­form for res­pi­ra­to­ry dis­eases

Last week
R&D
Cell/Gene Tx

Ex­clu­sive: Phar­ma­cy ad­her­ence start­up Sem­pre Health rais­es $20M

Last week
Financing
Health Tech

Ex­clu­sive: Two ex-Re­cur­sion lead­ers start Noetik in a bid to fix the bro­ken fun­nel in can­cer drug re­search

2 weeks ago
Financing

Ex­clu­sive: Dana­her’s ven­ture arm backs cell ther­a­py man­u­fac­tur­ing start­up co-found­ed by Carl June

2 weeks ago
Cell/Gene Tx
Manufacturing

Ex­clu­sive: Khosla Ven­tures leads seed round in mR­NA biotech look­ing to re­verse ag­ing by length­en­ing telom­eres

3 weeks ago
Financing

Stars align as ex-True North team nabs an­oth­er $90M to build out biotech con­stel­la­tion

3 weeks ago
Financing

Can­cer care start­up Thyme Care rais­es $60M, beat­ing the odds of rais­ing a Se­ries B dur­ing dig­i­tal health’s fund­ing slow­down

3 weeks ago
Financing
Health Tech

Ex­clu­sive: Stem cell sci­en­tist and bit.bio founder launch­es new start­up with goal of ex­tend­ing healthspan by 20 years

3 weeks ago
Financing

Scoop: Metageno­mi is prepar­ing for an IPO this fall, in what could jump­start a wave of pub­lic of­fer­ings

3 weeks ago
Financing

Lil­ly qui­et­ly com­pletes pur­chase of Pad­cev com­peti­tor, es­ti­mat­ed at near­ly half a bil­lion dol­lars

3 weeks ago
Deals
Pharma

Epi­genic Ther­a­peu­tics en­ters crowd­ed glob­al gene ther­a­py mar­ket with $32M Se­ries A

4 weeks ago
Financing

Cell ther­a­py start­up Notch Ther­a­peu­tics clos­es one of three sites

4 weeks ago
People
Cell/Gene Tx

i2o Ther­a­peu­tics clos­es $46M Se­ries A, names Kurt Graves as CEO and ac­quires Intar­cia’s twice-re­ject­ed di­a­betes as­set

4 weeks ago
People
Financing

For­mer Schrödinger ex­ec launch­es RA Cap­i­tal-backed start­up for AI drug dis­cov­ery

4 weeks ago
Financing

Neu­mora's big neu­ro­science plans head to­ward the Nas­daq in sec­ond PhI­II biotech IPO pitch in 24 hours

4 weeks ago
Financing

Ra­dio­phar­ma­ceu­ti­cals start­up Rayze­Bio sub­mits IPO pitch, fore­shad­ow­ing ex­pect­ed post-La­bor Day bump in biotech list­ings

4 weeks ago
Financing

Fore scores $75M Se­ries D, tees up new lead­er­ship with ex-El­e­va­tion CEO Shawn Le­land at the helm — for now

4 weeks ago
Financing
1234 Next page Last page
A service from the Financial Times